Does medication choice make a difference in functioning in first-episode psychosis? What antipsychotic may be coming to market? Learn the latest in treating psychosis from ACNP 2007. Medscape Psychiatry & Mental Health
After a phase 2a trial did not meet primary endpoint, a new phase 1 study of CERE-120 injected into both the substantia nigra and putamen is safe and feasible. Medscape Medical News
Levetiracetam decreases hippocampal hyperactivity in patients with amnestic mild cognitive impairment and may be useful in preventing or slowing the progression to Alzheimers disease. br / iMedscape Medical News/i
A new study indicates that 20% of children with ADD or learning disabilities have abnormal EEGs, but some of these normalize after puberty or treatment. Medscape Medical News